Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Natural Remedies

Researchers Find First Potential Pathogenic Mutation For Restless Legs Syndrome
An international team of researchers led by scientists at the Mayo Clinic campus in Florida have found what they believe is the first mutated gene linked to restless legs syndrome, a common neurologic disorder.
generic viagra online
Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R)
Data presented yesterday, in Budapest, demonstrated that add-on treatment with the novel, once-daily anti-epileptic Zebinix®* (eslicarbazepine acetate; ESL) resulted in a marked and sustained decrease in seizure frequency over the long-term. Results from the one-year extension of a pivotal Eslicarbazepine Acetate phase III study were presented at the International Congress for Epilepsy in Budapest, Hungary. Patients not controlled with existing anti-epileptic drugs who were given eslicarbazepine acetate as an add-on treatment experienced a mean reduction in seizure frequency of more than 61% (95%CI: -68.2%, -55.5%). Nearly 65% of patients were classified as responders, meaning that they had achieved at least a 50% reduction in seizure frequency with Zebinix® treatment1.
News of the day
FDA Approves VITROS(R) Anti-HCV Assay For Use On VITROS 5600(R) Integrated And VITROS 3600(R) Immunodiagnostic Systems
Ortho Clinical Diagnostics announced the U.S. Food and Drug Administration (FDA) approval of the VITROS((R)) Anti-HCV assay for use on the VITROS 5600((R)) Integrated and 3600((R)) Immunodiagnostic Systems. This approval marks a major milestone in the successful launches of Ortho Clinical Diagnostics" clinical laboratory testing platforms, and enables the consolidation of hepatitis C testing with routine assays on the VITROS((R)) 5600 Integrated System.
Oncology

Report On Contaminated Drinking Water At Camp Lejeune

Two chemicals - trichloroethylene (TCE) and tetrachloroethylene (PCE) - found to have contaminated drinking water at Marine Corps Base Camp Lejeune from the 1950s to 1985 have been linked to certain diseases and disorders, including various cancers. A new report from the National Research Council, Contaminated Water Supplies at Camp Lejeune - Assessing Potential Health Effects, reviews scientific evidence about the potential adverse health effects that could occur after exposure to TCE, PCE, and other contaminants; recommends the usefulness of conducting additional studies on former residents of the base; and identifies scientific considerations that could help the U.S. Department of the Navy, under which the Marine Corps operates, set priorities on future actions. The report will be released at a 90-minute public briefing. Details: The briefing will run from 11:30 a.m. to 1 p.m. on Saturday, June 13, at the USO of North Carolina, Jacksonville Center, 9 Tallman St., Jacksonville, N.C. Members of the committee participating in the briefing are: * David Savitz, chair of the committee and Charles W. Bluhdorn professor, Mount Sinai School of Medicine, New York City * Caroline Baier-Anderson, health scientist, Environmental Defense, and assistant professor, University of Maryland, Baltimore * Prabhakar Clement, professor of environmental engineering, Auburn University, Auburn, Ala. Jennifer Walsh National Academy of Sciences


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009